MPM BioImpact LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX)

Filing Manager: MPM BioImpact LLC
Reporting Manager: MPM BioImpact LLC
Security: Context Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol: CNTX
Shares outstanding: 92,063,716 shares
Disclosed Ownership: 10,679,391 shares
Ownership: 12%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 16:09:28 UTC
Date of event: 31 Dec 2025
Previous filing: 08 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
MPM BioImpact LLC	12%	10,679,391	10,679,391	0	Christopher Wolf	Chief Financial Officer